Loading insider details...
Latest Form 4 (Oct 27, 2026): Grant/Award of 383 ROIV shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 27, 2026 | Roivant Sciences Ltd. (ROIV) | Grant/Award | 383 | n/a |
| Sep 18, 2026 | Roivant Sciences Ltd. (ROIV) | Grant/Award | 5,054 | n/a |
| Sep 14, 2026 | Roivant Sciences Ltd. (ROIV) | Tax Withholding | 2,905 | $118.9K |
| Jul 22, 2026 | Roivant Sciences Ltd. (ROIV) | Grant/Award | 405 | n/a |
| Jun 24, 2026 | BridgeBio Pharma, Inc. (BBIO) | Grant/Award | 3,990 | n/a |
| Apr 21, 2026 | Roivant Sciences Ltd. (ROIV) | Grant/Award | 469 | n/a |
| Jan 23, 2026 | Roivant Sciences Ltd. (ROIV) | Grant/Award | 609 | n/a |
| Oct 23, 2025 | Roivant Sciences Ltd. (ROIV) | Grant/Award | 789 | n/a |
| Sep 13, 2025 | Roivant Sciences Ltd. (ROIV) | Grant/Award | 14,524 | n/a |
| Jul 22, 2025 | Roivant Sciences Ltd. (ROIV) | Grant/Award | 1,201 | n/a |